Logo image of NOT.DE

NOVARTIS AG-REG (NOT.DE) Stock Price, Quote, News and Overview

FRA:NOT - Deutsche Boerse Ag - CH0012005267 - Common Stock - Currency: EUR

102.98  +1.16 (+1.14%)

NOT.DE Quote, Performance and Key Statistics

NOVARTIS AG-REG

FRA:NOT (6/4/2025, 7:00:00 PM)

102.98

+1.16 (+1.14%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap203.39B
Shares1.98B
Float1.69B
Yearly Dividend3.35
Dividend Yield3.77%
PE14.15
Fwd PE12.94
Earnings (Next)07-17 2025-07-17/bmo
IPO05-07 2001-05-07


NOT.DE short term performance overview.The bars show the price performance of NOT.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 1 2 3

NOT.DE long term performance overview.The bars show the price performance of NOT.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of NOT.DE is 102.98 EUR. In the past month the price increased by 2.47%.

NOVARTIS AG-REG / NOT Daily stock chart

NOT.DE Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 55.4 634.80B
1LLY.MI ELI LILLY & CO 54.74 627.21B
ZEG.DE ASTRAZENECA PLC 16.65 396.54B
1JNJ.MI JOHNSON & JOHNSON 15.27 324.34B
JNJ.DE JOHNSON & JOHNSON 15.24 323.86B
NOV.DE NOVO NORDISK A/S-B 20.37 285.13B
RHO.DE ROCHE HOLDING AG-BR 15.39 249.90B
SAN.PA SANOFI 11.38 212.96B
SNW.DE SANOFI 11.33 212.07B
1NOVN.MI NOVARTIS AG-REG 13.6 195.53B
6MK.DE MERCK & CO. INC. 10.06 172.76B
1MRKX.MI MERCK & CO. INC. 10 171.75B

About NOT.DE

Company Profile

NOT logo image Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. The company is headquartered in Basel, Basel-Stadt and currently employs 75,883 full-time employees. The company went IPO on 2001-05-07. The firm develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The firm uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.

Company Info

NOVARTIS AG-REG

Lichtstrasse 35

Basel BASEL-STADT CH

Employees: 75883

NOT Company Website

NOT Investor Relations

Phone: 41613241111

NOVARTIS AG-REG / NOT.DE FAQ

What is the stock price of NOVARTIS AG-REG today?

The current stock price of NOT.DE is 102.98 EUR. The price increased by 1.14% in the last trading session.


What is the ticker symbol for NOVARTIS AG-REG stock?

The exchange symbol of NOVARTIS AG-REG is NOT and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is NOT.DE stock listed?

NOT.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for NOVARTIS AG-REG stock?

32 analysts have analysed NOT.DE and the average price target is 111.96 EUR. This implies a price increase of 8.72% is expected in the next year compared to the current price of 102.98. Check the NOVARTIS AG-REG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NOVARTIS AG-REG worth?

NOVARTIS AG-REG (NOT.DE) has a market capitalization of 203.39B EUR. This makes NOT.DE a Mega Cap stock.


How many employees does NOVARTIS AG-REG have?

NOVARTIS AG-REG (NOT.DE) currently has 75883 employees.


What are the support and resistance levels for NOVARTIS AG-REG (NOT.DE) stock?

NOVARTIS AG-REG (NOT.DE) has a support level at 100.39 and a resistance level at 102.99. Check the full technical report for a detailed analysis of NOT.DE support and resistance levels.


Is NOVARTIS AG-REG (NOT.DE) expected to grow?

The Revenue of NOVARTIS AG-REG (NOT.DE) is expected to grow by 7.74% in the next year. Check the estimates tab for more information on the NOT.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NOVARTIS AG-REG (NOT.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NOVARTIS AG-REG (NOT.DE) stock pay dividends?

NOVARTIS AG-REG (NOT.DE) has a dividend yield of 3.77%. The yearly dividend amount is currently 3.35. Check the full fundamental report for a detailed analysis of NOT.DE dividend history, reliability and sustainability.


When does NOVARTIS AG-REG (NOT.DE) report earnings?

NOVARTIS AG-REG (NOT.DE) will report earnings on 2025-07-17, before the market open.


What is the Price/Earnings (PE) ratio of NOVARTIS AG-REG (NOT.DE)?

The PE ratio for NOVARTIS AG-REG (NOT.DE) is 14.15. This is based on the reported non-GAAP earnings per share of 7.28 and the current share price of 102.98 EUR. Check the full fundamental report for a full analysis of the valuation metrics for NOT.DE.


NOT.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to NOT.DE.


Chartmill TA Rating
Chartmill Setup Rating

NOT.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to NOT.DE. NOT.DE has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NOT.DE Financial Highlights

Over the last trailing twelve months NOT.DE reported a non-GAAP Earnings per Share(EPS) of 7.28. The EPS increased by 18.6% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.15%
ROA 12.87%
ROE 33.51%
Debt/Equity 0.61
Chartmill High Growth Momentum
EPS Q2Q%26.67%
Sales Q2Q%9.18%
EPS 1Y (TTM)18.6%
Revenue 1Y (TTM)11.57%

NOT.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 68% to NOT.DE. The Buy consensus is the average rating of analysts ratings from 32 analysts.

For the next year, analysts expect an EPS growth of 11.31% and a revenue growth 7.74% for NOT.DE


Ownership
Inst Owners38.54%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A
Analysts
Analysts68.13
Price Target111.96 (8.72%)
EPS Next Y11.31%
Revenue Next Year7.74%